1. Home
  2. ATCH vs SCNI Comparison

ATCH vs SCNI Comparison

Compare ATCH & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATCH
  • SCNI
  • Stock Information
  • Founded
  • ATCH 2022
  • SCNI 2003
  • Country
  • ATCH United States
  • SCNI Israel
  • Employees
  • ATCH N/A
  • SCNI N/A
  • Industry
  • ATCH
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ATCH
  • SCNI Health Care
  • Exchange
  • ATCH Nasdaq
  • SCNI Nasdaq
  • Market Cap
  • ATCH 2.5M
  • SCNI 2.0M
  • IPO Year
  • ATCH N/A
  • SCNI N/A
  • Fundamental
  • Price
  • ATCH $0.18
  • SCNI $1.52
  • Analyst Decision
  • ATCH
  • SCNI
  • Analyst Count
  • ATCH 0
  • SCNI 0
  • Target Price
  • ATCH N/A
  • SCNI N/A
  • AVG Volume (30 Days)
  • ATCH 30.3M
  • SCNI 3.0M
  • Earning Date
  • ATCH 08-27-2025
  • SCNI 08-19-2025
  • Dividend Yield
  • ATCH N/A
  • SCNI N/A
  • EPS Growth
  • ATCH N/A
  • SCNI N/A
  • EPS
  • ATCH N/A
  • SCNI N/A
  • Revenue
  • ATCH $14,825,966.00
  • SCNI $658,000.00
  • Revenue This Year
  • ATCH N/A
  • SCNI N/A
  • Revenue Next Year
  • ATCH N/A
  • SCNI N/A
  • P/E Ratio
  • ATCH N/A
  • SCNI N/A
  • Revenue Growth
  • ATCH 1066.77
  • SCNI N/A
  • 52 Week Low
  • ATCH $0.14
  • SCNI $1.40
  • 52 Week High
  • ATCH $26.94
  • SCNI $6.18
  • Technical
  • Relative Strength Index (RSI)
  • ATCH 46.62
  • SCNI 29.96
  • Support Level
  • ATCH $0.17
  • SCNI $1.40
  • Resistance Level
  • ATCH $0.22
  • SCNI $1.64
  • Average True Range (ATR)
  • ATCH 0.03
  • SCNI 0.24
  • MACD
  • ATCH 0.00
  • SCNI -0.03
  • Stochastic Oscillator
  • ATCH 22.77
  • SCNI 5.77

About ATCH AtlasClear Holdings Inc. Common Stock

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: